BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

Arsenic Trioxide

An inorganic compound with the chemical formula As2O3 that is used for the treatment of ACUTE PROMYELOCYTIC LEUKEMIA in patients who have relapsed from, or are resistant to, conventional drug therapy.

298+ PubMed studies analyzed · 3 RCTs · Evidence Score: 42.8

Research Domains

Arsenic Trioxide has been studied across 15 research domains including 🔬 Oncology, 🫁 Liver & Detox, 🔬 Inflammation, 🧘 Stress & Anxiety, ⚡ Energy & Fatigue. The primary research focus is 🔬 Oncology with 55% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Arsenic Trioxide, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

Cetomacrogol
3 shared targets
dibekacin
2 shared targets
mezlocillin
2 shared targets
acivicin
3 shared targets
pyrrolnitrin
4 shared targets
Glycocholic
2 shared targets
Esculin
2 shared targets
Allylestrenol
2 shared targets
Metipranolol
2 shared targets
Testolactone
2 shared targets
Loading evidence profile...

This evidence profile for Arsenic Trioxide is generated deterministically from 298 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.